Epidermal growth factor receptor targeting in cancer: a review of trends and strategies

C Yewale, D Baradia, I Vhora, S Patil, A Misra - Biomaterials, 2013 - Elsevier
The epidermal growth factor receptor (EGFR) is a cell-surface receptor belonging to ErbB
family of tyrosine kinase and it plays a vital role in the regulation of cell proliferation, survival …

Untangling the ErbB signalling network

Y Yarden, MX Sliwkowski - Nature reviews Molecular cell biology, 2001 - nature.com
When epidermal growth factor and its relatives bind the ErbB family of receptors, they trigger
a rich network of signalling pathways, culminating in responses ranging from cell division to …

Epidermal growth factor receptor (EGFR) signaling in cancer

N Normanno, A De Luca, C Bianco, L Strizzi… - Gene, 2006 - Elsevier
The epidermal growth factor receptor (EGFR) belongs to the ErbB family of receptor tyrosine
kinases (RTK). These trans-membrane proteins are activated following binding with peptide …

Animal models and therapeutic molecular targets of cancer: utility and limitations

M Cekanova, K Rathore - Drug design, development and therapy, 2014 - Taylor & Francis
Cancer is the term used to describe over 100 diseases that share several common
hallmarks. Despite prevention, early detection, and novel therapies, cancer is still the …

Molecular mechanisms underlying ErbB2/HER2 action in breast cancer

D Harari, Y Yarden - Oncogene, 2000 - nature.com
Overexpression of ErbB2, a receptor-like tyrosine kinase, is shared by several types of
human carcinomas. In breast tumors the extent of overexpression has a prognostic value …

Epidermal growth factor receptor targeting in cancer

J Mendelsohn, J Baselga - Seminars in oncology, 2006 - Elsevier
The epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase of the ErbB family
that is abnormally activated in many epithelial tumors. Several mechanisms lead to the …

The deaf and the dumb: the biology of ErbB-2 and ErbB-3

A Citri, KB Skaria, Y Yarden - The EGF Receptor Family, 2003 - Elsevier
Publisher Summary This chapter focuses on the mechanisms of ligand-induced heterodimer
formation, and on signaling pathways employed by ErbB-2 and ErbB-3 in normal and …

[HTML][HTML] Optimal treatment for recurrent/metastatic head and neck cancer

JB Vermorken, P Specenier - Annals of oncology, 2010 - Elsevier
While a large proportion of patients presenting with stage I and II squamous cell carcinoma
of the head and neck (SCCHN) will remain disease free after single modality treatment, the …

[HTML][HTML] Molecular landscape of head and neck cancer and implications for therapy

CS Farah - Annals of Translational Medicine, 2021 - ncbi.nlm.nih.gov
Head and neck squamous cell carcinomas (HNSCC) arising from the oral cavity, pharynx,
and larynx constitute the 6 th most common human cancer. Human papillomavirus (HPV) …

Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway

HW Lo, SC Hsu, M Ali-Seyed, M Gunduz, W Xia, Y Wei… - Cancer cell, 2005 - cell.com
Epidermal growth factor receptor (EGFR) exists in the nucleus of highly proliferative cells
where it functions as a transcription factor. Although EGFR has transactivational activity, it …